Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation

被引:11
|
作者
Perez, Ariadna [1 ]
Montoro, Juan [2 ]
Hernani, Rafael [1 ]
Lorenzo, Ignacio [2 ]
Carlos Hernandez-Boluda, Juan [1 ,3 ]
Gimenez, Estela [4 ]
Dolores Gomez, Maria [5 ]
Balaguer-Rosello, Aitana [2 ]
Gonzalez-Barbera, Eva [5 ]
Guerreiro, Manuel [2 ]
Aguilar, Cristobal [2 ]
Navarro, David [3 ,4 ]
Solano, Carlos [1 ,3 ]
Sanz, Jaime [2 ,3 ,6 ]
Luis Pinana, Jose [2 ,6 ]
机构
[1] Fdn INCLIVA, Hosp Clin Univ, Dept Hematol, Valencia, Spain
[2] Hosp Univ & Politecn la Fe, Dept Hematol, Valencia, Spain
[3] Univ Valencia, Sch Med, Dept Med, Valencia, Spain
[4] Hosp Clin Univ, Microbiol Serv, Valencia, Spain
[5] Univ Valencia, Sch Med, Dept Microbiol, Valencia, Spain
[6] Inst Carlos III, CIBERONC, Madrid, Spain
关键词
allogeneic stem cell; community acquired respiratory virus; immunodeficiency scoring index; rhinovirus; trasplantation; HUMAN RHINOVIRUS INFECTIONS; INFLUENZA INFECTIONS; PARAINFLUENZA VIRUS; SYNCYTIAL VIRUS; RECIPIENTS; OUTCOMES; ADULTS; TRACT;
D O I
10.1111/tid.13301
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Enterovirus/rhinoviruses (EvRh) are the most common cause of respiratory virus infections in recipients of allogeneic stem cell transplantation (allo-HSCT). Objective We sought to analyze the value of the immunodeficiency scoring index (ISI) in predicting lower respiratory tract disease (LRTD) progression and mortality in a prospective cohort of consecutive adult (>16 years) allo-HSCT recipients with EvRh infection from December 1 2013 to December 1 2019 at two Spanish transplant centers. Results We included 234 allo-HSCT recipients with 383 EvRh episodes. Out of 383 EvRh episodes, 98 (25%) had LRTD. Multivariate logistic regression analysis identified three independent factors associated with LRTD progression: Ig G < 400 mg/dL, community-acquired respiratory virus (CARV) co-infection and high-risk ISI. Inclusion of Ig G levels and CARV co-infection in the ISI improved its performance by significantly increasing the area under the receiver operator characteristic curve (AUROC) from 0.643 to 0.734 (P = .03). Likewise, the two conditions identified by multivariate analyses as associated with higher probability of mortality were high-risk ISI and EvRh infection within 6 months after transplant. Conclusions Our findings confirm the value of high-risk ISI in predicting both probability of EvRh LRTD and 3-month overall mortality. We also demonstrate that the original ISI could be adapted to other CARV types by including additional variables to improve its performance.
引用
收藏
页数:12
相关论文
共 50 条
  • [21] Erythrocytosis after allogeneic hematopoietic stem cell transplantation
    Hino, Yutaro
    Doki, Noriko
    Kurosawa, Shuhei
    Yamamoto, Keita
    Sakaguchi, Masahiro
    Harada, Kaito
    Ikegawa, Shuntaro
    Shingai, Naoki
    Hattori, Kenichiro
    Senoo, Yasushi
    Igarashi, Aiko
    Najima, Yuho
    Kobayashi, Takeshi
    Kakihana, Kazuhiko
    Sakamaki, Hisashi
    Ohashi, Kazuteru
    CLINICAL TRANSPLANTATION, 2017, 31 (04)
  • [22] Jaundice After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendizabal, Manuel
    Chen, Terina
    Reddy, K. Rajender
    HEPATOLOGY, 2009, 50 (06) : 2044 - 2045
  • [23] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Q. Jiang
    B. H. Zhang
    Indian Journal of Hematology and Blood Transfusion, 2016, 32 : 504 - 506
  • [24] Malakoplakia After Allogeneic Hematopoietic Stem Cell Transplantation
    Robinson, Tracy
    Streu, Erin
    ONCOLOGY NURSING FORUM, 2015, 42 (05) : 558 - 561
  • [25] Rhabdomyolysis After Allogeneic Hematopoietic Stem Cell Transplantation
    Jiang, Q.
    Zhang, B. H.
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2016, 32 (04) : 504 - 506
  • [26] Plasticity after allogeneic hematopoietic stem cell transplantation
    Rovo, Alicia
    Gratwohl, Alois
    BIOLOGICAL CHEMISTRY, 2008, 389 (07) : 825 - 836
  • [27] Polyomaviruses After Allogeneic Hematopoietic Stem Cell Transplantation
    Mendoza, Maria Alejandra
    Imlay, Hannah
    VIRUSES-BASEL, 2025, 17 (03):
  • [28] Hyperlipidemia After Allogeneic Hematopoietic Stem Cell Transplantation
    Blaser, Bradley W.
    Kim, Haesook
    Plutzky, Jorge
    Alyea, Edwin, III
    Ho, Vincent
    Cutler, Corey
    Armand, Philippe
    Koreth, John
    Antin, Joseph H.
    Soiffer, Robert
    BLOOD, 2010, 116 (21) : 1419 - 1419
  • [29] Allogeneic hematopoietic stem cell transplantation for children with severe combined immunodeficiency
    Tezcan, I
    Turul, T
    Uckan, D
    Cetin, M
    Cüzdancy, H
    Sanal, Ö
    Ersoy, F
    BONE MARROW TRANSPLANTATION, 2003, 31 : S52 - S52
  • [30] ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PRIMARY IMMUNODEFICIENCY DISEASES IN BUDAPEST
    Horvath, Orsolya
    Kallay, Krisztian
    Benyo, Gabor
    Kassa, Csaba
    Strehn, Anita
    Sinko, Janos
    Csordas, Katalin
    Goda, Vera
    Krivan, Gergely
    JOURNAL OF CLINICAL IMMUNOLOGY, 2014, 34 (06) : 733 - 733